Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Morepen Laboratories Ltd (MOREPENLAB) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Active Pharmaceutical Ingredients (API)Bulk manufacture and export of APIs for anti-allergic, anti-asthmatic, cardiovascular, and anti-diabetic drugs.USFDA-approved facilities, patent-protected molecules, established export network.Pharmaceutical companies globally including regulated (USA, Europe) and non-regulated markets.Key APIs like Loratadine and cardiovascular drugs.98954B2B sales via exports and domestic supplies to pharmaceutical manufacturers.Contract pricing, long-term supply agreements.New molecule launches, enhanced market share in antihistamines and cardiovascular segments, export expansion.Loratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin
Home Diagnostic Medical DevicesManufacture and distribution of portable medical diagnostic devices for personal health monitoring.Strong brand recognition, technology integration, in-house manufacturing.Consumers, pharmacies, healthcare providers in India and international markets.Blood glucose monitoring devices.49727B2C sales and B2B sales through retail and medical channels.Product sales via retail and online channels.Rising health awareness, device innovation, increased distribution reach.Dr. Morepen Glucometers, Blood Pressure Monitors, Pregnancy Test Kits
Pharmaceutical Formulations and Over-the-Counter (OTC) ProductsPrescription formulations, branded generics, and self-medication OTC healthcare products.Recognized OTC brands, growing domestic presence, strategic subsidiary operations.End consumers (B2C), hospitals and clinics (B2B).OTC flagship products and branded generics.34419Sales through retail pharmacies, institutional supply, and contract manufacturing agreements.Retail pricing, institutional contracts, and supply agreements.OTC portfolio expansion, generics market growth, strategic brand realignment.Burnol, Lemolate, C Candy, Pain-X, Omega Fish Oil

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions